SE0302487D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE0302487D0
SE0302487D0 SE0302487A SE0302487A SE0302487D0 SE 0302487 D0 SE0302487 D0 SE 0302487D0 SE 0302487 A SE0302487 A SE 0302487A SE 0302487 A SE0302487 A SE 0302487A SE 0302487 D0 SE0302487 D0 SE 0302487D0
Authority
SE
Sweden
Prior art keywords
sup
novel compounds
compounds
racemates
tautomers
Prior art date
Application number
SE0302487A
Other languages
English (en)
Inventor
Peter Hansen
Hans Loenn
Antonios Nikitidis
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29212489&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE0302487(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0302487A priority Critical patent/SE0302487D0/sv
Publication of SE0302487D0 publication Critical patent/SE0302487D0/sv
Priority to TW093127678A priority patent/TW200526579A/zh
Priority to AT04775439T priority patent/ATE420861T1/de
Priority to PCT/SE2004/001336 priority patent/WO2005026124A1/en
Priority to MXPA06002723A priority patent/MXPA06002723A/es
Priority to UAA200602252A priority patent/UA84878C2/ru
Priority to ES04775439T priority patent/ES2319300T3/es
Priority to US10/572,640 priority patent/US20070043036A1/en
Priority to BRPI0414570-4A priority patent/BRPI0414570A/pt
Priority to CA002538410A priority patent/CA2538410A1/en
Priority to CNB2004800275174A priority patent/CN100439339C/zh
Priority to DE602004019110T priority patent/DE602004019110D1/de
Priority to AU2004272485A priority patent/AU2004272485B2/en
Priority to JP2006526856A priority patent/JP2007505902A/ja
Priority to EP04775439A priority patent/EP1663974B1/en
Priority to RU2006112427/04A priority patent/RU2348617C2/ru
Priority to UY28513A priority patent/UY28513A1/es
Priority to KR1020067005458A priority patent/KR20060096995A/ko
Priority to ARP040103354A priority patent/AR046083A1/es
Priority to SA4250300A priority patent/SA04250300B1/ar
Priority to IL173986A priority patent/IL173986A0/en
Priority to CO06026211A priority patent/CO5670357A2/es
Priority to ZA200602262A priority patent/ZA200602262B/xx
Priority to IS8394A priority patent/IS8394A/is
Priority to NO20061700A priority patent/NO20061700L/no
Priority to HK06109477.7A priority patent/HK1089167A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
SE0302487A 2003-09-18 2003-09-18 Novel compounds SE0302487D0 (sv)

Priority Applications (26)

Application Number Priority Date Filing Date Title
SE0302487A SE0302487D0 (sv) 2003-09-18 2003-09-18 Novel compounds
TW093127678A TW200526579A (en) 2003-09-18 2004-09-13 Novel compounds
UY28513A UY28513A1 (es) 2003-09-18 2004-09-15 Nuevos compuestos
KR1020067005458A KR20060096995A (ko) 2003-09-18 2004-09-15 중성구 엘라스타제 억제제로서의 2-피리돈 유도체 및 그의용도
DE602004019110T DE602004019110D1 (de) 2003-09-18 2004-09-15 2-pyridonderivate als inhibitoren von neutrophilelastase und deren verwendung
JP2006526856A JP2007505902A (ja) 2003-09-18 2004-09-15 好中球エラスターゼ阻害剤としての２−ピリドン誘導体およびその使用
MXPA06002723A MXPA06002723A (es) 2003-09-18 2004-09-15 Derivados de 2-piridona como inhibidores de neutrofilo elastasa y su uso.
UAA200602252A UA84878C2 (ru) 2003-09-18 2004-09-15 Производные 2-пиридона как ингибиторы нейтрофилов эластазы, фармацевтическая композиция на их основе, способ их получения
ES04775439T ES2319300T3 (es) 2003-09-18 2004-09-15 Derivados de 2-piridona como inhibidores de elastasa neutrofila y su uso.
US10/572,640 US20070043036A1 (en) 2003-09-18 2004-09-15 2-Pyridone derivatives as neutrophil elastase inhibitors and their use
BRPI0414570-4A BRPI0414570A (pt) 2003-09-18 2004-09-15 derivados de 2-piridona como inibidores de elastase de neutrófilo e seu uso
CA002538410A CA2538410A1 (en) 2003-09-18 2004-09-15 2-pyridone derivatives as netrophil elastase inhibitors and their use
CNB2004800275174A CN100439339C (zh) 2003-09-18 2004-09-15 用作嗜中性白细胞弹性蛋白酶抑制剂的2-吡啶酮衍生物及其用途
AT04775439T ATE420861T1 (de) 2003-09-18 2004-09-15 2-pyridonderivate als inhibitoren von neutrophilelastase und deren verwendung
AU2004272485A AU2004272485B2 (en) 2003-09-18 2004-09-15 2-pyridone derivatives as neutrophil elastase inhibitors and their use
PCT/SE2004/001336 WO2005026124A1 (en) 2003-09-18 2004-09-15 2-pyridone derivatives as netrophil elastase inhibitors and their use
EP04775439A EP1663974B1 (en) 2003-09-18 2004-09-15 2-pyridone derivatives as netrophil elastase inhibitors and their use
RU2006112427/04A RU2348617C2 (ru) 2003-09-18 2004-09-15 Производные 2-пиридона в качестве ингибиторов эластазы нейтрофилов и их применение
ARP040103354A AR046083A1 (es) 2003-09-18 2004-09-17 Derivados de 2 piridona como inhibidores de la elastasa de neutrofilos
SA4250300A SA04250300B1 (ar) 2003-09-18 2004-09-18 مشتقات 2_ بيريدون تعمل كمثبطات لانزيم ايلاستيز النتيروفيل واستخدامها
IL173986A IL173986A0 (en) 2003-09-18 2006-02-27 2-pyridone derivatives as netrophil elastase inhibitors and their use
CO06026211A CO5670357A2 (es) 2003-09-18 2006-03-15 Derivados de 2-piridona como inhibidores de elastasa neutrofila y su uso
ZA200602262A ZA200602262B (en) 2003-09-18 2006-03-17 2-Pyridone derivatives as neutrophil elastase inhibitors and their use
IS8394A IS8394A (is) 2003-09-18 2006-03-31 2-pýridónafleiður sem daukyrningselastasatálmar og notkun þeirra
NO20061700A NO20061700L (no) 2003-09-18 2006-04-18 2-pyridonderivater som neutrofil elastase inhibitorer og deres anvendelse
HK06109477.7A HK1089167A1 (en) 2003-09-18 2006-08-25 2-pyridone derivatives as netrophil elastase inhibitors and their use 2-

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0302487A SE0302487D0 (sv) 2003-09-18 2003-09-18 Novel compounds

Publications (1)

Publication Number Publication Date
SE0302487D0 true SE0302487D0 (sv) 2003-09-18

Family

ID=29212489

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0302487A SE0302487D0 (sv) 2003-09-18 2003-09-18 Novel compounds

Country Status (26)

Country Link
US (1) US20070043036A1 (sv)
EP (1) EP1663974B1 (sv)
JP (1) JP2007505902A (sv)
KR (1) KR20060096995A (sv)
CN (1) CN100439339C (sv)
AR (1) AR046083A1 (sv)
AT (1) ATE420861T1 (sv)
AU (1) AU2004272485B2 (sv)
BR (1) BRPI0414570A (sv)
CA (1) CA2538410A1 (sv)
CO (1) CO5670357A2 (sv)
DE (1) DE602004019110D1 (sv)
ES (1) ES2319300T3 (sv)
HK (1) HK1089167A1 (sv)
IL (1) IL173986A0 (sv)
IS (1) IS8394A (sv)
MX (1) MXPA06002723A (sv)
NO (1) NO20061700L (sv)
RU (1) RU2348617C2 (sv)
SA (1) SA04250300B1 (sv)
SE (1) SE0302487D0 (sv)
TW (1) TW200526579A (sv)
UA (1) UA84878C2 (sv)
UY (1) UY28513A1 (sv)
WO (1) WO2005026124A1 (sv)
ZA (1) ZA200602262B (sv)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200500341A (en) * 2002-11-12 2005-01-01 Astrazeneca Ab Novel compounds
SE0302486D0 (sv) 2003-09-18 2003-09-18 Astrazeneca Ab Novel compounds
TW200700392A (en) * 2005-03-16 2007-01-01 Astrazeneca Ab Novel compounds
PL1928454T3 (pl) * 2005-05-10 2015-03-31 Intermune Inc Pochodne pirydonu do modulowania układu kinazy białkowej aktywowanego stresem
RU2442771C2 (ru) 2005-08-08 2012-02-20 Арджента Дискавери Лтд Производные бицикло[2,2,1]гепт-7-иламина и их применения
GB0516313D0 (en) 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
JP2009509979A (ja) * 2005-09-29 2009-03-12 ユニバーシティ オブ アルバータ グランザイムｂ阻害のための組成物および方法
GB0605469D0 (en) * 2006-03-17 2006-04-26 Argenta Discovery Ltd Multimers of heterocyclic compounds and their use
TW200808771A (en) * 2006-05-08 2008-02-16 Astrazeneca Ab Novel compounds II
TW200808763A (en) * 2006-05-08 2008-02-16 Astrazeneca Ab Novel compounds I
EP2077262A4 (en) 2006-10-23 2011-12-28 Takeda Pharmaceutical IMINOPYRIDINE DERIVATIVES AND THEIR USE
CN101535264B (zh) 2006-11-08 2012-11-28 百时美施贵宝公司 吡啶酮化合物
MX2010004673A (es) * 2007-11-06 2010-05-27 Astrazeneca Ab Algunos derivados de 2-pirazinona y su uso como inhibidores de elastasa de los neutrofilos.
AU2008337342B2 (en) 2007-12-14 2012-05-24 Pulmagen Therapeutics (Asthma) Limited Indoles and their therapeutic use
NZ586630A (en) 2008-01-23 2011-12-22 Bristol Myers Squibb Co 4-Pyridinone compounds and their use for cancer
US8481569B2 (en) 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof
US8304413B2 (en) 2008-06-03 2012-11-06 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
GB0902648D0 (en) 2009-02-17 2009-04-01 Argenta Discovery Ltd Pharmaceutical compounds and compositions
CN102395586A (zh) 2009-02-17 2012-03-28 奇斯药制品公司 作为p38map激酶抑制剂的三唑并吡啶衍生物
TW201036957A (en) * 2009-02-20 2010-10-16 Astrazeneca Ab Novel salt 628
AU2010302420B2 (en) * 2009-10-02 2013-07-04 Astrazeneca Ab 2-pyridone compounds used as inhibitors of neutrophil elastase
GB0918922D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Aminopyridine derivatives
GB0918924D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Azaindole derivatives
GB0918923D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Aminothiazole derivatives
AU2010328480A1 (en) * 2009-12-08 2012-05-17 Boehringer Ingelheim International Gmbh Process for synthesis of intermediates useful for making substituted indazole and azaindazole compounds
GB201009731D0 (en) 2010-06-10 2010-07-21 Pulmagen Therapeutics Inflamma Kinase inhibitors
CN104024241B (zh) 2011-08-01 2016-01-20 大日本住友制药株式会社 尿嘧啶衍生物和其用于医学目的的用途
WO2013083604A1 (en) 2011-12-09 2013-06-13 Chiesi Farmaceutici S.P.A. Kinase inhibitors
KR20140105459A (ko) 2011-12-09 2014-09-01 키에시 파르마슈티시 엣스. 피. 에이. 키나아제 억제제
KR20140103925A (ko) 2011-12-09 2014-08-27 키에시 파르마슈티시 엣스. 피. 에이. 4-히드록시-1,2,3,4-테트라히드로나프탈렌-1-일 우레아 및 호흡기 질환의 치료에서의 이들의 용도
US20140057926A1 (en) 2012-08-23 2014-02-27 Boehringer Ingelheim International Gmbh Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
US20140057920A1 (en) 2012-08-23 2014-02-27 Boehringer Ingelheim International Gmbh Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
US9102624B2 (en) 2012-08-23 2015-08-11 Boehringer Ingelheim International Gmbh Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
US9181242B2 (en) 2013-06-06 2015-11-10 Chiesi Farmaceutici S.P.A. Kinase inhibitors
US9221807B2 (en) 2014-02-21 2015-12-29 Boehringer Ingelheim International Gmbh Substituted pyridones and pyrazinones and their use as inhibitors of neutrophil elastase activity
MX2016012808A (es) 2014-04-02 2017-01-05 Intermune Inc Piridinonas anti-fibroticas.
TWI724022B (zh) 2015-09-02 2021-04-11 英商葛蘭素史密斯克藍智慧財產權有限公司 化合物
TW201720828A (zh) 2015-11-23 2017-06-16 赫孚孟拉羅股份公司 治療性化合物及組合物以及其使用方法
AR107165A1 (es) 2015-12-23 2018-03-28 Chiesi Farm Spa Inhibidores de quinasa
MA44131A (fr) 2015-12-23 2021-05-26 Chiesi Farm Spa Dérivés de 1-(3-tert-butyl-2h-pyrazol-5-yl or 5-tert-butyl-isoxaol-3-yl)-3-(4-([1,2,4]triazolo[4,3-a]pyridin-6-yloxy)-1,2,3,4-tetrahydro-naphthalenyl) urée et leur utlisation en tant qu'inhibiteurs de p38 mapk
AR107163A1 (es) 2015-12-23 2018-03-28 Chiesi Farm Spa Inhibidores de quinasa
EP3452464B1 (en) 2016-05-05 2021-12-15 F. Hoffmann-La Roche AG Pyrazole derivatives, compositions and therapeutic use thereof
KR20190045302A (ko) 2016-09-06 2019-05-02 에프. 호프만-라 로슈 아게 8-(아제티딘-1-일)-[1,2,4]트라이아졸로[1,5-a]피리딘일 화합물 및 이의 조성물 및 사용 방법
PE20191236A1 (es) 2016-12-29 2019-09-11 Hoffmann La Roche Compuestos de pirazolopirimidina y metodos de uso de los mismos
EP3596072B1 (en) 2017-03-14 2022-06-22 F. Hoffmann-La Roche AG Pyrazolochlorophenyl compounds, compositions and methods of use thereof
TW201900648A (zh) 2017-05-22 2019-01-01 瑞士商赫孚孟拉羅股份公司 治療性化合物及組成物以及其使用方法
US10307426B2 (en) 2017-05-22 2019-06-04 Genentech, Inc. Therapeutic compounds and compositions, and methods of use thereof
US10364245B2 (en) 2017-06-07 2019-07-30 Chiesi Farmaceutici S.P.A. Kinase inhibitors
WO2019139714A1 (en) 2018-01-15 2019-07-18 Genentech, Inc. Pyrazolopyrimidine compounds as jak inhibitors
EP3749697A4 (en) 2018-02-05 2021-11-03 Bio-Rad Laboratories, Inc. CHROMATOGRAPHIC RESIN WITH A LIGAND WITH ANION EXCHANGE-HYDROPHOBIC MIXED MODE
CN110192948B (zh) * 2019-05-28 2022-01-04 河南省超亚医药器械有限公司 一种小儿腹部热敷贴
CN110192947B (zh) * 2019-05-28 2022-01-04 河南省超亚医药器械有限公司 一种小儿肺部热敷贴
WO2020257142A1 (en) 2019-06-18 2020-12-24 Genentech, Inc. Tetrazole-substituted pyrazolopyrimidine inhibitors of jak kinases and uses thereof
JP2022537964A (ja) 2019-06-18 2022-08-31 エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト Ｊａｋキナーゼのピラゾロピリミジンスルホン阻害剤およびその使用
WO2020257143A1 (en) 2019-06-18 2020-12-24 Genentech, Inc. Pyrazolopyrimidine aryl ether inhibitors of jak kinases and uses thereof
WO2021053058A1 (en) 2019-09-17 2021-03-25 Mereo Biopharma 4 Limited Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
DK4106757T3 (da) 2020-04-16 2023-10-23 Mereo Biopharma 4 Ltd Fremgangsmåder der involverer neutrofil elastase-inhibitor alvelestat til behandling af luftvejssygdom medieret af alpha-1-antitrypsin-mangel
WO2023067103A1 (en) 2021-10-20 2023-04-27 Mereo Biopharma 4 Limited Neutrophil elastase inhibitors for use in the treatment of fibrosis
CN114057630B (zh) * 2021-12-23 2023-06-02 郑州大学 吡非尼酮衍生物及其合成方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521179A (en) * 1991-04-18 1996-05-28 Zeneca Limited Heterocyclic amides
GB9207145D0 (en) * 1991-04-18 1992-05-13 Ici Plc Heterocyclic amides
CN100575345C (zh) * 2000-12-28 2009-12-30 盐野义制药株式会社 对2型大麻素受体具有结合活性的吡啶酮衍生物
GB0129260D0 (en) * 2001-12-06 2002-01-23 Eisai London Res Lab Ltd Pharmaceutical compositions and their uses
DE60214428T2 (de) * 2001-12-20 2007-09-20 Bayer Healthcare Ag 1, 4-dihydro-1, 4-diphenylpyridin-derivate
GB2383326A (en) * 2001-12-20 2003-06-25 Bayer Ag Antiinflammatory dihydropyridines
TW200500341A (en) * 2002-11-12 2005-01-01 Astrazeneca Ab Novel compounds
SE0302486D0 (sv) * 2003-09-18 2003-09-18 Astrazeneca Ab Novel compounds

Also Published As

Publication number Publication date
NO20061700L (no) 2006-04-18
SA04250300B1 (ar) 2008-09-07
TW200526579A (en) 2005-08-16
MXPA06002723A (es) 2006-06-06
HK1089167A1 (en) 2006-11-24
AU2004272485B2 (en) 2008-03-13
CA2538410A1 (en) 2005-03-24
ATE420861T1 (de) 2009-01-15
IL173986A0 (en) 2006-07-05
EP1663974B1 (en) 2009-01-14
CO5670357A2 (es) 2006-08-31
BRPI0414570A (pt) 2006-11-07
DE602004019110D1 (de) 2009-03-05
WO2005026124A1 (en) 2005-03-24
JP2007505902A (ja) 2007-03-15
ES2319300T3 (es) 2009-05-06
CN1856467A (zh) 2006-11-01
US20070043036A1 (en) 2007-02-22
RU2006112427A (ru) 2007-11-10
ZA200602262B (en) 2007-07-25
RU2348617C2 (ru) 2009-03-10
UY28513A1 (es) 2005-04-29
KR20060096995A (ko) 2006-09-13
IS8394A (is) 2006-03-31
AR046083A1 (es) 2005-11-23
AU2004272485A1 (en) 2005-03-24
CN100439339C (zh) 2008-12-03
UA84878C2 (ru) 2008-12-10
EP1663974A1 (en) 2006-06-07

Similar Documents

Publication Publication Date Title
SE0302487D0 (sv) Novel compounds
SE0302324D0 (sv) Novel compounds
SE0302486D0 (sv) Novel compounds
SE0302323D0 (sv) Novel compounds
MY137133A (en) Novel compounds
MX2007009372A (es) Nuevos compuestos ii derivados de 2-piridina como inhibidores de elastasa neutrofila.
SE0202463D0 (sv) Novel compounds
ECSP044992A (es) Inhibidores de la alquín-aril fosfodiesterasa-4
SE0302139D0 (sv) Novel compounds
ATE386725T1 (de) Heterocyclylverbindungen
SE0203304D0 (sv) Novel Coumpounds
SE0102055D0 (sv) New Compounds
SE0302756D0 (sv) Novel Compounds
SE0303280D0 (sv) Novel compounds
SE0202461D0 (sv) Novel compounds
SE0102641D0 (sv) Novel compounds
DE60103034D1 (de) Neue phenylheteroalkylamin-derivate
SE9904676D0 (sv) Novel compounds
SE0403118D0 (sv) New compounds 2
SE9901901D0 (sv) Compounds
SE0102640D0 (sv) Novel compounds
SE0403117D0 (sv) New compounds 1
SE0103325D0 (sv) Novel compounds
SE0302120D0 (sv) Novel compounds
SE0202280D0 (sv) Novel compounds